Bruce G. Allen Investments’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8K Hold
110
0.02% 386
2026
Q1
$20.2K Hold
110
0.01% 399
2025
Q4
$19.4K Hold
110
0.01% 404
2025
Q3
$15.4K Buy
110
+5
+5% +$676 0.01% 428
2025
Q2
$13.2K Buy
105
+38
+57% +$4.74K 0.01% 440
2025
Q1
$9.17K Buy
67
+44
+191% +$6.29K 0.01% 473
2024
Q4
$3.52K Sell
23
-14
-38% -$2.36K ﹤0.01% 634
2024
Q3
$7.17K Sell
37
-19
-34% -$3.98K 0.01% 524
2024
Q2
$13K Buy
56
+29
+107% +$6.3K 0.01% 425
2024
Q1
$5.82K Sell
27
-9
-25% -$2.11K ﹤0.01% 565
2023
Q4
$9.32K Buy
+36
New +$8.84K 0.01% 487

Other funds holding BIIB

Bruce G. Allen Investments's BIIB Position: Q2 2026 in Review

Bruce G. Allen Investments held its Biogen (BIIB) position steady in Q2 2026 at 110 shares worth $23.8K. The position accounts for 0.02% of the portfolio, ranked #386.

Bruce G. Allen Investments first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Bruce G. Allen Investments held 110 shares of Biogen worth $23.8K as of Q2 2026.
  • Bruce G. Allen Investments left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of Bruce G. Allen Investments's portfolio in Q2 2026, its #386 holding.
  • Bruce G. Allen Investments first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.